Nicholas Investment Partners’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
AIM
NAMA
Nicholas Investment Partners's EXAS Position: Q3 2022 in Review
Nicholas Investment Partners sold out of Exact Sciences (EXAS) in Q3 2022, closing a stake of 115,092 shares — an estimated $4.53M sold.
Nicholas Investment Partners first reported a position in EXAS in Q2 2013 and held it in 24 quarters. The position peaked at $22.2M in Q1 2021. 480 funds tracked by Wall St. Rank hold EXAS as of Q3 2022.
- Nicholas Investment Partners reported no remaining Exact Sciences position as of Q3 2022 after selling out during the quarter.
- Nicholas Investment Partners sold 115,092 Exact Sciences shares in Q3 2022, an estimated $4.53M.
- Nicholas Investment Partners first reported a position in Exact Sciences in Q2 2013 and held it in 24 quarters.
- Nicholas Investment Partners's Exact Sciences position peaked at $22.2M in Q1 2021.
- 480 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2022.
Based on Nicholas Investment Partners's 13F filing for Q3 2022, filed 14 Nov 2022.